The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial

BACKGROUND: Patients with haematological malignancies often develop thrombocytopenia as a consequence of either their disease or its treatment. Platelet transfusions are commonly given to raise a low platelet count and reduce the risk of clinical bleeding (prophylaxis) or stop active bleeding (thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Estcourt, Lise J., McQuilten, Zoe, Powter, Gillian, Dyer, Claire, Curnow, Eleanor, Wood, Erica M., Stanworth, Simon J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792262/
https://www.ncbi.nlm.nih.gov/pubmed/31615553
http://dx.doi.org/10.1186/s13063-019-3663-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792262/
https://www.ncbi.nlm.nih.gov/pubmed/31615553
http://dx.doi.org/10.1186/s13063-019-3663-2

Ejemplares similares